FDA Inspection 682755 — Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited — FEI 3002808311

The FDA completed an inspection of Takeda Pharmaceutical Company Limited on September 14, 2010 in Yodogawa-Ku. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 14, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yodogawa-Ku (Japan)